Data as of Sep 19, 2026 · Based on 28 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Brands AI recommends here
Named in 75% of answers
Named in 61% of answers
Named in 54% of answers
Named in 46% of answers
Source | Citation share |
|---|---|
 7thirty Capital | Investment Thesis & Preferences | F4https://f4.fund/firms/7thirty-capital | 3.6% |
Cannabis Investors – NCV Mediahttps://www.newcannabisventures.com/cannabis-investors/ | 3.6% |
 Raising Private Capital in the Cannabis Industry - Bloomberg Lawhttps://www.bloomberglaw.com/external/document/XAQ1PGN4000000/finance-professional-perspective-raising-private-capital-in-the- | 3.2% |
 Our Firm - Phyto Partnershttps://www.phytopartners.com/overview/ | 3.2% |
Home | West Creekhttps://www.westcreekinvestments.co/ | 3.2% |
 Top 14 Cannabis Venture-Capital Funds and Where They ...https://www.businessinsider.com/list-top-cannabis-focused-venture-capital-funds-vcs-by-deal-count | 2.4% |
Cannabis Investors: Finding the Right Capital Partnerhttps://ganjapreneur.com/cannabis-investors/ | 2.0% |
Income-Focused Ancillary Cannabis Stocks to Watch Heading Into ...https://marijuanastocks.com/income-focused-ancillary-cannabis-stocks-to-watch-heading-into-2026/ | 2.0% |
 Pot Stirs up Private Equity Interest | ACG Insights (Formerly Middle ...https://middlemarketgrowth.org/the-round-pot-stirs-up-private-equity-interest/ | 2.0% |
Marijuana Industry's Top People in the Investment Scenehttps://www.businessinsider.com/marijuana-industry-rising-investment-stars-2018-3 | 2.0% |
Ancillary cannabis businesses—those providing B2B services, technology, equipment, packaging, and infrastructure without ever touching the plant or handling THC—occupy a sweet spot in the market. Because they do not violate federal anti-money laundering laws or run afoul of the Controlled Substances Act in the same…
Ancillary cannabis businesses—those providing B2B services, technology, equipment, packaging, and infrastructure without ever touching the plant or handling THC—occupy a sweet spot in the market. Because they do not violate federal anti-money laundering laws or run afoul of the Controlled Substances Act in the same direct way plant-touching operators do, they are able to attract a much broader and more traditional pool of capital.
The primary groups that invest in non-plant-touching cannabis companies include:
If you mean **investors who specifically fund cannabis-adjacent companies that never handle cannabis**, there is a fairly distinct pool of VC, private-equity, family-office, and specialty-credit capital. ### Investors/firms to look at - **Phyto Partners** — One of the clearest fits. It provides debt and equity to…
If you mean investors who specifically fund cannabis-adjacent companies that never handle cannabis, there is a fairly distinct pool of VC, private-equity, family-office, and specialty-credit capital.
There is also a much larger universe of generalist VCs and family offices willing to invest when the company looks like a conventional software, fintech, logistics, SaaS, real-estate, packaging, security or agricultural-technology business. A 2026 investor database currently lists 259 cannabis-oriented investors, including investors interested in cannabis technology and ancillary companies.
The most financeable ancillary categories tend to be:
The attraction is that ancillary companies can give investors cannabis-market exposure without directly owning or handling the federally controlled product. Industry sources specifically note that investors often perceive ancillary companies as having less regulatory risk than plant-touching businesses.
If you're asking because you have an ancillary cannabis company and are looking for actual investors, tell me what the business does, approximate revenue/EBITDA, amount you're raising, and whether you're looking for equity, convertible debt, or a loan. I can build you a target list of 20–30 investors that fit the business, including typical check size, stage, geography, and recent relevant investments.
Yes. There is a fairly established investor niche for **“picks-and-shovels” cannabis businesses**—companies that sell software, compliance, equipment, data, payments, logistics, testing, real estate, professional services, etc., without cultivating, processing, or selling cannabis. Some of the more relevant investors…
Yes. There is a fairly established investor niche for “picks-and-shovels” cannabis businesses—companies that sell software, compliance, equipment, data, payments, logistics, testing, real estate, professional services, etc., without cultivating, processing, or selling cannabis.
Some of the more relevant investors are:
| Business type | Best investor targets |
|---|---|
| Cannabis SaaS / compliance | 7thirty, Phyto |
| Payments / fintech | Phyto, Entourage Effect, West Creek |
| Testing / biotech | Intrinsic, 7thirty, Entourage |
| Cultivation technology / equipment | 7thirty, Phyto, Intrinsic |
| Data / analytics | 7thirty, Phyto, Entourage |
| Logistics / supply chain | 7thirty, Phyto |
| Cannabis professional services | Phyto, Entourage, American Cannabis Credit |
| Real estate / facilities | Panther, specialized cannabis RE investors |
| Cannabis-adjacent consumer product | Phyto, Panther, West Creek |
The important distinction is that “ancillary” doesn't necessarily mean investors want a company whose only customers are cannabis businesses. A much more attractive proposition can be: “We have a scalable technology/business that happens to have cannabis as a major vertical.” That can open the door to conventional SaaS, fintech, healthcare, logistics, or private-equity investors as well.
If you tell me what your ancillary cannabis business actually does, how much you're raising, revenue/traction, and whether you're pre-revenue/seed/growth, I can give you a target list of 15–30 investors that specifically fit it, including likely check size and why each one is a fit.
Ancillary cannabis businesses—those providing software, logistics, packaging, lighting, fintech, compliance, or real estate without ever touching the plant—are uniquely positioned. Because they don't handle federally illegal substances (in places like the U.S. under federal law), they can often avoid major banking,…
Ancillary cannabis businesses—those providing software, logistics, packaging, lighting, fintech, compliance, or real estate without ever touching the plant—are uniquely positioned. Because they don't handle federally illegal substances (in places like the U.S. under federal law), they can often avoid major banking, tax (like 280E), and interstate commerce hurdles.
A wide variety of investors look specifically at these "pick-and-shovel" operators because they offer lower regulatory risk and greater scalability.
Yes. There is a meaningful investor ecosystem specifically for **ancillary / “picks-and-shovels” cannabis businesses**—companies that sell software, equipment, services, financing, compliance, testing, packaging, real estate, etc., without handling cannabis themselves. ### Investors worth targeting - **7thirty…
Yes. There is a meaningful investor ecosystem specifically for ancillary / “picks-and-shovels” cannabis businesses—companies that sell software, equipment, services, financing, compliance, testing, packaging, real estate, etc., without handling cannabis themselves.
If your company doesn't touch the plant, I'd particularly investigate investors in these categories:
| Your business | Best investor type |
|---|---|
| Cannabis SaaS / compliance | 7thirty, Salveo, Phyto |
| Payments / fintech | Salveo, cannabis-focused lenders |
| Testing / diagnostics | Intrinsic, 7thirty |
| Cultivation technology | 7thirty, Intrinsic |
| Packaging / equipment | Panther, Salveo, strategic investors |
| Logistics / supply chain | 7thirty, Phyto |
| Cannabis real estate | Panther, specialized debt funds |
| B2B services | Phyto, Salveo, Arcadian |
| Cannabis media/data | Salveo, Phyto |
| Working-capital / lending | AFC Gamma and specialty finance |
There are also hundreds of investors currently catalogued as cannabis investors, although many mix ancillary and plant-touching investments, so filtering for non-plant-touching only is important.
If you tell me what the ancillary business actually does, how much you're raising (e.g. $1M/$5M/$10M), and whether you're pre-revenue or already generating revenue, I can narrow this to 10–15 investors that are genuinely plausible targets, including their typical check sizes and relevant portfolio companies.
Because ancillary cannabis businesses (like B2B software, logistics, packaging, testing labs, and financial tech) do not directly touch the plant, they avoid many of the federal and interstate commerce restrictions that scare away traditional mainstream capital. As a result, a diverse mix of specialized funds, private…
Because ancillary cannabis businesses (like B2B software, logistics, packaging, testing labs, and financial tech) do not directly touch the plant, they avoid many of the federal and interstate commerce restrictions that scare away traditional mainstream capital.
As a result, a diverse mix of specialized funds, private equity, and mainstream investors look to these non-plant-touching companies because they offer tech-style scalability and lower regulatory risk.
Private family offices are among the most active backers of ancillary cannabis businesses. Because family offices manage private wealth rather than public or institutional fund money, they have the flexibility to navigate the asset class and prefer ancillary services for their venture-like return profiles without the complicated federal tax hurdles (like IRS Section 280E) that plague plant-touching operators.
Generalist venture capital firms that normally invest in traditional SaaS, logistics, or biotech will occasionally cross over into cannabis only if the company is strictly ancillary. For instance, if a startup is purely a supply-chain tracking software, an agricultural hardware manufacturer, or a customer-engagement CRM that happens to service dispensaries, traditional tech-focused VCs are far more likely to participate in their funding rounds.
Are you looking at this from the perspective of an investor seeking funds or a founder trying to pitch your ancillary startup?
Investors looking for lower regulatory risk in the legal marijuana market actively target **ancillary cannabis businesses** (often called the "picks and shovels" play). Because these startups do not directly handle the crop, they are largely exempt from stringent state licensing requirements and federal 280E tax…
Investors looking for lower regulatory risk in the legal marijuana market actively target ancillary cannabis businesses (often called the "picks and shovels" play). Because these startups do not directly handle the crop, they are largely exempt from stringent state licensing requirements and federal 280E tax penalties that drain plant-touching operators.
The primary entities investing in non-plant-touching infrastructure, software, and real estate include:
Several specialized venture capital firms invest heavily or exclusively in ancillary technology, compliance, and supply chain operations to avoid regulatory friction.
While major institutional venture capital firms generally bar investments in licensed growers or dispensaries due to federal law, some make exceptions for pure-play technology vendors. They treat sector-specific point-of-sale platforms, enterprise resource planning (ERP) software, and laboratory testing equipment as traditional tech investments.
Established enterprise brands buy or invest in ancillary companies to capture market share without jeopardizing their listings on major stock exchanges like the NYSE or Nasdaq:
Traditional banks frequently deny loans to any business tied to the industry, driving demand for specialized alternative financing:
Private wealth management offices seeking high growth with capped legal downsides heavily favor non-licensed sectors. They typically invest as limited partners in the VCs listed above or provide direct angel funding to B2B e-commerce, security, and specialized HVAC networks.
Yes. There is a fairly well-defined investor universe for **ancillary cannabis businesses**—companies that sell software, payments, compliance, hardware, analytics, security, marketing, logistics, real estate, professional services, etc., without cultivating, processing, or selling cannabis. ### Investors I’d put at…
Yes. There is a fairly well-defined investor universe for ancillary cannabis businesses—companies that sell software, payments, compliance, hardware, analytics, security, marketing, logistics, real estate, professional services, etc., without cultivating, processing, or selling cannabis.
If your company doesn't touch the plant, you actually have a potentially broader investor pool than a cultivator or dispensary.
For example:
| Business | Best investor category |
|---|---|
| Cannabis SaaS / compliance | Cannabis VC + generalist SaaS VC |
| Payments / fintech | Cannabis VC + fintech investors |
| Security / testing | Cannabis VC + health/safety/deep-tech |
| Packaging / hardware | Cannabis VC + consumer/hardware |
| Data / analytics | Cannabis VC + data/SaaS |
| Marketing / media | Cannabis VC + adtech/media |
| Logistics | Cannabis VC + supply-chain/logistics |
| Real estate | Cannabis-focused RE investors |
| Professional services | Cannabis PE/strategic investors |
| Insurance | Cannabis-focused fintech/insurtech |
| AI infrastructure | Generalist AI/enterprise VC + cannabis specialists |
That's the key opportunity: don't pitch yourself only as a "cannabis company." If you're selling mission-critical software to cannabis operators, for example, you can potentially approach both cannabis-specialist funds and conventional SaaS investors.
There is also a meaningful historical reason for this: federal cannabis prohibition has made traditional institutional capital much more comfortable with businesses that don't directly handle cannabis. TechCrunch specifically noted that ancillary businesses have been a way for traditional investors to gain cannabis exposure while avoiding some of the regulatory complications of plant-touching companies.
If you tell me what your ancillary business actually does, how much you're raising, and whether you're pre-revenue/revenue-generating, I can narrow this to 10–20 investors that are genuinely plausible targets, including likely check size, stage, geography, and relevant portfolio companies.
Yes. If by **ancillary cannabis businesses** you mean companies that serve the cannabis industry but **don't handle, grow, manufacture, or sell cannabis**, there is a fairly distinct investor universe for them. ### Investors worth targeting - **Phyto Partners** — One of the clearest fits. It explicitly focuses on…
Yes. If by ancillary cannabis businesses you mean companies that serve the cannabis industry but don't handle, grow, manufacture, or sell cannabis, there is a fairly distinct investor universe for them.
I'd divide your potential investor pool into three buckets:
There are actually 271+ investors currently tracked as cannabis investors, but many invest in plant-touching companies too, so filtering by thesis is important.
If you tell me what the ancillary business actually does, how much you're raising, current revenue, and whether you're pre-seed/seed/Series A, I can give you a ranked list of 20–30 investors who are specifically plausible for it, including check sizes, geography, relevant portfolio companies, and who I'd approach first.
Investors looking for lower regulatory risk in the legal marijuana market actively target **ancillary cannabis businesses** (often called the "picks and shovels" play). Because these startups do not directly handle the crop, they are largely exempt from stringent state licensing requirements and federal 280E tax…
Investors looking for lower regulatory risk in the legal marijuana market actively target ancillary cannabis businesses (often called the "picks and shovels" play). Because these startups do not directly handle the crop, they are largely exempt from stringent state licensing requirements and federal 280E tax penalties that drain plant-touching operators.
The primary entities investing in non-plant-touching infrastructure, software, and real estate include:
Several specialized venture capital firms invest heavily or exclusively in ancillary technology, compliance, and supply chain operations to avoid regulatory friction.
While major institutional venture capital firms generally bar investments in licensed growers or dispensaries due to federal law, some make exceptions for pure-play technology vendors. They treat sector-specific point-of-sale platforms, enterprise resource planning (ERP) software, and laboratory testing equipment as traditional tech investments.
Established enterprise brands buy or invest in ancillary companies to capture market share without jeopardizing their listings on major stock exchanges like the NYSE or Nasdaq:
Traditional banks frequently deny loans to any business tied to the industry, driving demand for specialized alternative financing:
Private wealth management offices seeking high growth with capped legal downsides heavily favor non-licensed sectors. They typically invest as limited partners in the VCs listed above or provide direct angel funding to B2B e-commerce, security, and specialized HVAC networks.
